(Q33602161)

28 July 2017

U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

1 reference

1 reference

Mayer B Davidson

1

1 reference

28 July 2017

Maria D Navar

series ordinal

2

1 reference

28 July 2017

Diana Echeverry

series ordinal

3

1 reference

28 July 2017

Petra Duran

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

12 November 2009

1 reference

28 July 2017

1 reference

28 July 2017

33

1 reference

28 July 2017

2

1 reference

28 July 2017

281-283

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

28 July 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

High-dose insulin therapy: is it time for U-500 insulin?

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809265

The use of U-500 in patients with extreme insulin resistance

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809265

Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809265

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19910500

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC09-1490

1 reference

28 July 2017

1 reference

28 July 2017

1 reference